The outcome verify conclusions drawn by Bagli et al. [one], who carried out a study that integrated 10 patients diagnosed with CRAO who gained HBOT. Together with obtaining twenty sessions of HBOT, oral acetazolamide and topical beta-blockers had been administered into the patients with the earliest feasible time.“Dr. Weber and his team had been